EZH2 and breast carcinoma: Using the Kaplan-Meier Plotter (KM Plotter) database (50), we found that higher EZH2 expression was associated with poor survival outcomes for patients with breast cancer, as well as patients with breast cancer with lymph nodule metastasis (Supplemental Figure 8, A and B).